Corporate News     08-Dec-23
Marksans Pharma receives upgrade in credit ratings
Marksans Pharma has received upgrade in credit ratings for bank facilities from India Ratings and Research as under:

Fund based limits (Rs 100 crore) - IND A+/ Positive
Non fund based limits (Rs 77 crore) - IND A1+

Previous News
  Marksans Pharma consolidated net profit rises 29.26% in the June 2024 quarter
 ( Results - Announcements 14-Aug-24   07:54 )
  Marksans Pharma standalone net profit declines 22.22% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   14:28 )
  Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   15:15 )
  Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter
 ( Results - Announcements 13-Feb-24   16:31 )
  Marksans Pharma arm receives marketing authorization for Ibuprofen and Paracetamol
 ( Hot Pursuit - 25-Feb-25   12:45 )
  Marksans Pharma consolidated net profit rises 14.97% in the June 2023 quarter
 ( Results - Announcements 12-Aug-23   07:46 )
  Relonchem receives marketing authorization for Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets
 ( Corporate News - 25-Feb-25   12:31 )
  Marksans Pharma consolidated net profit rises 34.64% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:45 )
  Marksans Pharma consolidated net profit declines 3.87% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:22 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 31-May-23   12:46 )
  Marksans Pharma arm receives UK MHRA approval for four products
 ( Corporate News - 02-Jul-24   13:41 )
Other Stories
  TAC Infosec to table results
  28-Apr-25   10:12
  Steel City Securities to conduct board meeting
  28-Apr-25   10:11
  Par Drugs & Chemicals announces board meeting date
  28-Apr-25   10:10
  Vedavaag Systems to hold board meeting
  28-Apr-25   09:28
  Nila Infrastructures to announce Quarterly Result
  28-Apr-25   09:28
  Adani Enterprises to conduct board meeting
  28-Apr-25   09:27
  Standard Capital Markets to conduct board meeting
  28-Apr-25   09:27
  Parshva Enterprises to discuss results
  28-Apr-25   09:25
  Samsrita Labs to convene board meeting
  28-Apr-25   09:25
  Vippy Spinpro to convene board meeting
  28-Apr-25   09:25
Back Top